Advertisement

Spatiotemporal characteristics of fibroblasts-dependent cancer cell invasion

  • Tomoyuki Miyashita
  • Tomokazu Omori
  • Hiroshi Nakamura
  • Masato Sugano
  • Shinya Neri
  • Satoshi Fujii
  • Hiroko Hashimoto
  • Masahiro Tsuboi
  • Atsushi Ochiai
  • Genichiro IshiiEmail author
Original Article – Cancer Research
  • 51 Downloads

Abstract

Purpose

Cancer cells can invade the surrounding stroma with the aid of fibroblasts (fibroblasts-dependent invasion). The aim of this study was to explore the spatiotemporal characteristics of fibroblast-dependent invasion of cancer cells.

Methods

We performed an in vitro three-dimensional collagen invasion assay using Fluorescent Ubiquitination-based Cell Cycle indicator (Fucci)-labeled A431 carcinoma cells co-cultured with fibroblasts. We used time-lapse imaging to analyze the total cell number, frequencies of small cancer cell nests and S/G2/M phase of A431 cells in the invasion area. We compared the frequencies of small cancer cell nests and geminin (+) cancer cells within fibroblast-rich areas and fibroblast-poor areas in surgically resected human invasive squamous cell carcinoma tissue.

Results

The total invasion number of A431 cells was significantly higher when cultured with fibroblasts than without. The formation of small cancer cell nests was observed within the invasion area only in the presence of fibroblasts. The frequency of S/G2/M phase cells was significantly higher in A431 cells when cultured with fibroblasts than without. Immunohistochemical analysis of surgically resected human invasive squamous cell carcinoma tissue revealed that the frequencies of small cancer cell nests and geminin-positive cancer cells were significantly higher in fibroblast-rich areas compared to those in fibroblast-poor areas within the same tumor region.

Conclusion

Our current study clearly showed that fibroblast-dependent cancer cell invasion was characterized by the progression in cell cycle and formation of small cancer cell nests.

Keywords

Squamous cell carcinoma Fucci Cell cycle Invasion Fibroblasts 

Abbreviations

CAFs

Cancer-associated fibroblasts

DMEM

Dulbecco’s modified Eagle’s medium

ECM

Extracellular matrix

Fucci

Fluorescent ubiquitination-based cell cycle indicator

HRP

Horseradish peroxidase

MMP

Matrix metalloproteinase

Notes

Acknowledgements

This work was supported in part by the National Cancer Center Research and Development Fund (23-A-12), and JSPS KAKENHI (24659185 and 16H05311). Tomoyuki Miyashita and Genichiro Ishii designed the study; Tomoyuki Miyashita performed in vitro experiments and analyzed the data; Tomokazu Omori, Hiroshi Nakamura, Masahiro Tsuboi, Masato Sugano, Genichiro Ishii and Tomoyuki Miyashita analyzed clinical and pathological data; Shinya Neri and Hiroko Hashimoto, Satoshi Fujii and Atsushi Ochiai provided intellectual advice; Tomoyuki Miyashita, and Genichiro Ishii wrote the manuscript.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Comprehensive informed consent was obtained from all individual participants included in the study.

Supplementary material

432_2018_2798_MOESM1_ESM.pptx (1.6 mb)
Supp Fig. 1: Schema of the 3-dimensional collagen invasion assay. (a) Schema of the experiment of A431 cells monoculture. A431-Fucci cells were seeded on collagen-coated dish and scratched. After that, they were embedded in collagen type I matrix and observed every 3 h. (b) Schema of the experiment of A431 cells co-cultured with fibroblasts. Same number of A431-Fucci cells and fibroblasts were seeded. Similar protocol was followed as with the A431 cells in monoculture. Blue arrow indicates the direction of invasion. Supp Fig. 2: Representative images of A431-Fucci cells. (a) Representative image of cell cycle progression in A431 cells in monoculture at 27, 39, and 45 h. White arrow indicates single invaded A431 cell with progression of cell cycle. Left panel: A431 cell in G1 phase, middle panel: A431 cell in S/G2/M phase, right panel: two daughter cells in G1 phase. (a) Representative images of cell cycle progression in A431 cells co-cultured with fibroblasts at 7.5, 15, and 27 h. White arrow indicates single invaded A431 cell with progression of cell cycle. Left panel: A431 cell in G1 phase, middle panel: A431 cell in S/G2/M phase, right panel: two daughter cells in G1 phase. Supp Fig. 3: Frequency of S/G2/M phase in A431 cells in 2D culture. The average ratio of S/G2/M phase in cancer cells at 72 h. Values are given as mean ± S.D. from three independent experiments. Statistical analysis was performed using Student’s t-test. ***p< 0.01 (PPTX 1610 KB)
432_2018_2798_MOESM2_ESM.xlsx (10 kb)
Supplementary material 2 (XLSX 10 KB)

References

  1. Christiansen JJ, Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319–8326CrossRefGoogle Scholar
  2. Clark AG, Vignjevic DM (2015) Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 36:13–22CrossRefGoogle Scholar
  3. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174CrossRefGoogle Scholar
  4. Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009CrossRefGoogle Scholar
  5. Friedl P, Wolf K (2003) Tumour-cell invasion and migration diversity and escape mechanisms. Nat Rev Cancer 3:362–374CrossRefGoogle Scholar
  6. Friedl P, Wolf K (2009) Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev 28:129–135CrossRefGoogle Scholar
  7. Friedl P, Locker J, Sahai E, Segall JE (2012) Classifying collective cancer cell invasion. Nat Cell Biol 14:777–783CrossRefGoogle Scholar
  8. Funai K, Yokose T, Ishii G, Araki K, Yoshida J, Nishimura M, Nagai K, Nishiwaki Y, Ochiai A (2003) Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol 27:978–984CrossRefGoogle Scholar
  9. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9:1392–1400CrossRefGoogle Scholar
  10. Gao Y, Wang Z, Hao Q, Li W, Xu Y, Zhang J, Zhang W, Wang S, Liu S, Li M, Xue X, Zhang W, Zhang C, Zhang Y (2017) Loss of ERalpha induces amoeboid-like migration of breast cancer cells by downregulating vinculin. Nat Commun 8:14483CrossRefGoogle Scholar
  11. Ishii G, Ochiai A, Neri S (2016) Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev 99:186–196CrossRefGoogle Scholar
  12. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392–401CrossRefGoogle Scholar
  13. Khalil AA, Friedl P (2010) Determinants of leader cells in collective cell migration. Integr Biol (Camb) 2:568–574CrossRefGoogle Scholar
  14. Konen J, Summerbell E, Dwivedi B, Galior K, Hou Y, Rusnak L, Chen A, Saltz J, Zhou W, Boise LH, Vertino P, Cooper L, Salaita K, Kowalski J, Marcus AI (2017) Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion. Nat Commun 8:15078CrossRefGoogle Scholar
  15. Labernadie A, Kato T, Brugues A, Serra-Picamal X, Derzsi S, Arwert E, Weston A, Gonzalez-Tarrago V, Elosegui-Artola A, Albertazzi L, Alcaraz J, Roca-Cusachs P, Sahai E, Trepat X (2017) A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol 19:224–237CrossRefGoogle Scholar
  16. Lammermann T, Sixt M (2009) Mechanical modes of ‘amoeboid’ cell migration. Curr Opin Cell Biol 21:636–644CrossRefGoogle Scholar
  17. Madsen CD, Sahai E (2010) Cancer dissemination–lessons from leukocytes. Dev Cell 19:13–26CrossRefGoogle Scholar
  18. Miyashita T, Higuchi Y, Kojima M, Ochiai A, Ishii G (2017) Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells. Sci Rep 7:39971CrossRefGoogle Scholar
  19. Neri S, Ishii G, Hashimoto H, Kuwata T, Nagai K, Date H, Ochiai A (2015) Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Int J Cancer 137:784–796CrossRefGoogle Scholar
  20. Neri S, Hashimoto H, Kii H, Watanabe H, Masutomi K, Kuwata T, Date H, Tsuboi M, Goto K, Ochiai A, Ishii G (2016) Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts. J Cancer Res Clin Oncol 142:437–446CrossRefGoogle Scholar
  21. Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, Watanabe H, Kuwata T, Tsuboi M, Goto K, Menju T, Sonobe M, Date H, Ochiai A, Ishii G (2017) Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma. Cancer Lett 395:20–30CrossRefGoogle Scholar
  22. Sahai E (2007) Illuminating the metastatic process. Nat Rev Cancer 7:737–749CrossRefGoogle Scholar
  23. Sakaue-Sawano A, Kobayashi T, Ohtawa K, Miyawaki A (2011) Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol 12:2CrossRefGoogle Scholar
  24. Sanz-Moreno V, Marshall CJ (2010) The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol 22:690–696CrossRefGoogle Scholar
  25. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510–523CrossRefGoogle Scholar
  26. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG (2011) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12:39–50CrossRefGoogle Scholar
  27. Skhinas JN, Cox TR (2017) The interplay between extracellular matrix remodelling and kinase signalling in cancer progression and metastasis. Cell Adh Migr 1–9Google Scholar
  28. Sleeman JP, Thiery JP: SnapShot (2011) The epithelial-mesenchymal transition. Cell 145:162 e1Google Scholar
  29. Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69:7135–7139CrossRefGoogle Scholar
  30. Wolf K, Friedl P (2011) Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. Trends Cell Biol 21:736–744CrossRefGoogle Scholar
  31. Wolf K, Muller R, Borgmann S, Brocker EB, Friedl P (2003) Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 102:3262–3269CrossRefGoogle Scholar
  32. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P (2007) Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9:893–904CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Tomoyuki Miyashita
    • 1
    • 2
  • Tomokazu Omori
    • 2
    • 3
  • Hiroshi Nakamura
    • 2
    • 4
  • Masato Sugano
    • 2
    • 4
  • Shinya Neri
    • 2
  • Satoshi Fujii
    • 2
  • Hiroko Hashimoto
    • 2
  • Masahiro Tsuboi
    • 3
  • Atsushi Ochiai
    • 1
    • 5
  • Genichiro Ishii
    • 1
    • 2
    Email author
  1. 1.Laboratory of Cancer Biology, Department of Integrated Biosciences, Graduate School of Frontier SciencesThe University of TokyoKashiwaJapan
  2. 2.Division of Pathology, Exploratory Oncology Research and Clinical Trial CenterNational Cancer CenterKashiwaJapan
  3. 3.Division of Thoracic SurgeryNational Cancer Center Hospital EastKashiwaJapan
  4. 4.Department of Pathology and Clinical LaboratoriesNational Cancer Center Hospital EastKashiwaJapan
  5. 5.Exploratory Oncology Research and Clinical Trial CenterNational Cancer CenterKashiwaJapan

Personalised recommendations